PedAM
Pediatric Disease Annotations & Medicines
| Disease | hyperglycemia |
| Symptom | |diabetes mellitus |
| Sentences | 78 |
| PubMedID- 22837722 | Metformin is a biguanide drug that is broadly used in clinical practice to prevent hyperglycemia in patients with diabetes mellitus. |
| PubMedID- 23423609 | Nonenzymatic glycation of macromolecules, especially proteins leading to their oxidation is increased in diabetes mellitus due to hyperglycemia and play an important role in associated complications of the disease. |
| PubMedID- 23576884 | Background: the purpose of this paper is to review the efficacy, safety, and tolerability of linagliptin in the management of hyperglycemia in adults with type 2 diabetes mellitus. |
| PubMedID- 23614630 | The position statement on the management of hyperglycemia in patients with type 2 diabetes mellitus issued in 2012 by the american diabetes association and the european association for the study of diabetes contains significant improvements over the 2009 version, including an emphasis on patient-centered care, enhanced strategies for lifestyle modification, a focus on comprehensive cardiovascular risk reduction, and increased pharmacotherapy choices. |
| PubMedID- 21713092 | The three major metabolic abnormalities that contribute to hyperglycemia in diabetes mellitus are defective glucose-induced insulin secretion, increased hepatic glucose output and inability of insulin to stimulate glucose uptake in the peripheral target tissues. |
| PubMedID- 26167540 | hyperglycemia in diabetes mellitus causes oxidative stress and pericyte depletion from the microvasculature of the brain thus leading to the blood-brain barrier (bbb) disruption. |
| PubMedID- 24465132 | When contraindications to its use exist or patients cannot tolerate it due to adverse effects, clinicians have a variety of other classes of agents to treat hyperglycemia associated with type 2 diabetes mellitus. |
| PubMedID- 25705228 | To prevent worsening hyperglycemia with underlying diabetes mellitus, steroids were avoided and the patient was started on an immunosuppressant, azathioprine. |
| PubMedID- 22211582 | Efficacy of protamine zinc recombinant human insulin for controlling hyperglycemia in dogs with diabetes mellitus. |
| PubMedID- 26141922 | hyperglycemia in diabetes mellitus causes glycation of membrane enzymes along with oxidative stress leading to decrease in activity of na+/k+-atpase and other changes in erythrocyte membranes 1. |
| PubMedID- 25918533 | A 30-year-old obese male patient had been diagnosed with diabetes mellitus due to acute hyperglycemia and ketonuria. |
| PubMedID- 25759411 | Proper keratinocyte migration and proliferation are the crucial steps during reepithelialization, and these steps may be impaired in diabetes mellitus (dm) due to hyperglycemia and chronic inflammation in wound site. |
| PubMedID- 21286019 | Glucocorticoids not only exacerbate hyperglycemia in patients with known diabetes mellitus (dm), but also cause dm in patients without documented hyperglycemia before the initiation of glucocorticoid therapy (2). |
| PubMedID- 22649411 | In hyperglycemia, as with diabetes mellitus and metabolic syndrome, high activity of the krebs cycle due to high substrate availability may increase the h+ gradient over the mitochondrial membrane (figure 2a), leading to inhibition of enzymatic steps mediated by complexes within the electron transport chain, including succinate dehydrogenase (complex ii; figure 2a; brownlee, 2005). |
| PubMedID- 22238392 | Context: dapagliflozin, a selective sodium-glucose cotransporter 2 (sglt2) inhibitor, reduces hyperglycemia in patients with type 2 diabetes mellitus (t2dm) by increasing urinary glucose excretion, and weight loss is a consistent associated finding. |
| PubMedID- 22683753 | hyperglycemia in association with diabetes mellitus makes esrd patients resistant to hcy-lowering therapy. |
| PubMedID- 25536610 | Patients with diabetes mellitus or other causes of hyperglycemia were excluded, as pleural fluid glucose has been reported to be sensitive to serum glucose fluctuations. |
| PubMedID- 21030101 | Remission of diabetes mellitus type 2 with severe hyperglycemia after exenatide treatment. |
| PubMedID- 26345606 | Persistent hyperglycemia in patients with diabetes mellitus is said to be associated with various complications. |
| PubMedID- 22086363 | In the surgical population, hyperglycemia with or without diabetes mellitus may be unrecognized. |
| PubMedID- 24250607 | Several drugs such as sulfonylureas and biguanides are presently available to reduce hyperglycemia in diabetes mellitus. |
| PubMedID- 21159853 | After extending previous evidence that leptin infusion directly into the lateral cerebral ventricle ameliorates hyperglycemia in rats with streptozotocin-induced uncontrolled diabetes mellitus, we showed that the underlying mechanism is independent of changes of food intake, urinary glucose excretion, or recovery of pancreatic beta-cells. |
| PubMedID- 24341330 | The persistent hyperglycemia in patients with type 2 diabetes mellitus is strongly associated with microvascular and macrovascular complications 1. |
| PubMedID- 24790413 | Basal-bolus insulin therapy is an ideal regimen for improving uncontrolled hyperglycemia in patients with diabetes mellitus.1 prandial premixed insulin therapy (ppt), injected three times a day, is also effective for glycemic control in type 2 diabetics.2–9 further, ppt is convenient for patients, because it requires only a single insulin preparation. |
| PubMedID- 23320026 | hyperglycemia associated with diabetes mellitus can be controlled by diet management, exercise, oral hypoglycemic agents, and insulin therapy. |
| PubMedID- 24857350 | Background: chorea is a common presenting feature of metabolic disorders, including nonketotic hyperglycemia in patients with type 2 diabetes mellitus, but rarely has been reported in diabetic ketoacidosis, hypothyroidism and vitamin b12 deficiency. |
| PubMedID- 22489155 | diabetes mellitus patients with long-term hyperglycemia produce more ofr due to increased glucose autoxidation and protein saccharification, which weakens oxidation resistance and initiates oxidation stress . |
| PubMedID- 24375463 | Introduction: hyperglycemia associated with diabetes mellitus (dm) has adverse impacts on peripheral nerve connective tissue structure, and there is preliminary evidence that nerve biomechanics may be altered. |
Page: 1 2